한글목차

세계의 섬유근육통 치료 시장은 2025년에는 31억 8,000만 달러로 추정되며, 2032년에는 40억 5,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 3.5%로 성장할 것으로 예측됩니다.

도표. 섬유근육통 치료 시장 점유율(%), 2025년 지역별

섬유근육통은 근육, 인대, 힘줄의 만성적이고 광범위한 통증과 압통을 특징으로 하는 질환입니다. 종종 피로, 수면장애, 기억력 장애, 기분 장애를 동반하는 경우가 많습니다. 섬유근육통의 정확한 원인은 아직 밝혀지지 않았지만, 뇌의 신경 화학적 불균형이 원인으로 여겨지고 있습니다. 그 증상은 고통받는 사람들의 삶의 질에 부정적인 영향을 미칩니다. 현재로서는 섬유근육통을 치료할 수 있는 방법은 없지만, 치료는 증상을 관리하고 일상생활의 기능을 개선하는 것을 목표로 합니다. 일반적인 치료법으로는 약수처리, 생활습관 개선, 대체요법, 인지행동치료 등이 있습니다. 세계 섬유근육통 치료 시장은 진단율 증가와 증상에 대한 인식이 높아짐에 따라 큰 성장이 예상됩니다.

시장 역학:

세계 섬유근육통 치료 시장은 전 세계 섬유근육통 유병률 증가에 의해 주도되고 있습니다. 섬유근육통은 전 세계 인구의 약 2-8%가 앓고 있는 것으로 추정됩니다. 또한 섬유근육통 치료를 위한 새로운 약물 제제의 승인 증가도 시장 성장을 가속하고 있습니다. 그러나 높은 치료비용과 치료법이 확립되지 않은 점이 시장 잠재력을 저해하고 있습니다. 또한 의사들의 인식 부족도 문제점으로 지적되고 있습니다. 시장 개발자들은 섬유근육통 치료를 위한 새로운 제제를 개발하여 저렴한 가격으로 치료 옵션을 제공할 수 있는 기회를 얻고 있습니다. 생물제제의 채택 증가는 새로운 성장의 길을 열어줄 것입니다.

본 조사의 주요 특징

• 세계의 섬유근육통 치료제 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(BN$)와 연평균 성장률(CAGR%)을 조사하여 전해드립니다.
• 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 섬유근육통 치료제 시장의 주요 업체를 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 섬유근육통 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 섬유근육통 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 파이프라인 분석
• 특허 소송
• 상환
• 특허 상황(ANDA/NDA 인텔리전스)
• PEST 분석
• Porter의 산업 분석

제4장 세계의 섬유근육통 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 섬유근육통 치료 시장, 약제 클래스별, 2020-2032년, (10억 달러)

• 항우울제
• 항간질약
• 근이완제
• 진통제
• 기타

제6장 세계의 섬유근육통 치료 시장, 유통 채널별, 2020-2032년, (10억 달러)

• 병원 약국
• 소매 약국
• 온라인 약국

제7장 세계의 섬유근육통 치료 시장, 지역별, 2020-2032년, (10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 히트맵 분석
• 기업 개요
  • Eli Lilly and Company
  • Pfizer, Inc.
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd.
  • Aptinyx, Inc.
  • Prismic Pharmaceuticals, Inc.
  • Innovative Med Concepts, Inc.
  • Intec Pharma Ltd
  • Astellas Pharma Inc.
  • Johnson &Johnson
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

제9장 애널리스트의 시점

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Fibromyalgia Treatment Market is estimated to be valued at USD 3.18 Bn in 2025 and is expected to reach USD 4.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2032.

Figure. Fibromyalgia Treatment Market Share (%), By Region 2025

Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.

Market Dynamics:

The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.

Key Features of the Study:

• This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global fibromyalgia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.

Market Segmentation

• Drug Class:
  • Antidepressants
  • Antiepileptics
  • Muscle Relaxants
  • Analgesics
  • Others
• Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Eli Lilly and Company
  • Pfizer Inc.
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd.
  • Aptinyx Inc.
  • Prismic Pharmaceuticals Inc.
  • Innovative Med Concepts Inc.
  • Intec Pharma Ltd.
  • Astellas Pharma Inc.
  • Johnson & Johnson
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Patent Litigations
• Reimbursement
• Patent Landscape (ANDA/NDA Intelligence)
• PEST Analysis
• Porter's Analysis

4. Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Fibromyalgia Treatment Market, By Drug Class, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Antidepressants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
  • Segment Trends
• Antiepileptics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
  • Segment Trends
• Muscle Relaxants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Analgesics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Fibromyalgia Treatment Market, By Distribution Channel, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Fibromyalgia Treatment Market, By Region, 2020 - 2032, (USD BN)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD BN)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Allergan plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Aptinyx, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Prismic Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Innovative Med Concepts, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Intec Pharma Ltd
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact